Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy B London

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup studyNeyssa Marina, Wendy B London, A Lindsay Frazier, et al.
Frontiers in Oral Health|January 20, 2022
The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral MucositisAther Adnan, Anna N Yaroslavsky, James D Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor)Joanne P Lagmay, Wendy B London, Thomas G Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group studyRani E George, Wendy B London, Susan L Cohn, et al.
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in childrenJennifer T Huang, Johanna S Song, Elena B Hawryluk, et al.
Pediatric Blood & Cancer|May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
American Journal of Hematology|January 13, 2015
Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictorsCraig M Forester, Sarah E Sartain, Dongjing Guo, et al.
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
Cancer Research|September 1, 2010
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastomaRuey-Jen Lin, You-Chin Lin, Jeremy Chen, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup studyNeyssa Marina, Wendy B London, A Lindsay Frazier, et al.
Frontiers in Oral Health|January 20, 2022
The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral MucositisAther Adnan, Anna N Yaroslavsky, James D Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor)Joanne P Lagmay, Wendy B London, Thomas G Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group studyRani E George, Wendy B London, Susan L Cohn, et al.
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in childrenJennifer T Huang, Johanna S Song, Elena B Hawryluk, et al.
Pediatric Blood & Cancer|May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
American Journal of Hematology|January 13, 2015
Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictorsCraig M Forester, Sarah E Sartain, Dongjing Guo, et al.
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
Cancer Research|September 1, 2010
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastomaRuey-Jen Lin, You-Chin Lin, Jeremy Chen, et al.
Pageof 23